Cancer on the agenda of the Portuguese EU Council Presidency

July 05, 2007

The European Society for Medical Oncology (ESMO) is proud to announce that it is collaborating closely with the Portuguese EU Presidency on a key European meeting on health care issues, where cancer will be an important part of the agenda.

The 'Round Table on Health Strategies in the European Union' (Lisbon, 12-13 July 2007) is one of the most important initiatives launched by the EU Portuguese Presidency within the context of the EU strategy on health policy, focusing on the topic of health and migration. ESMO has been invited by Dr. Joaquim Gouveia, National Coordinator of Oncological Diseases in Portugal, to be a key partner in this meeting for aspects related to cancer.

Under the broad theme of creating a 'European Health Strategy', this Round Table will address crucial issues in terms of the EU health agenda, such as facing specific health problems, health determinants, health services and patient mobility.

"The selection of such topics reflects the importance politicians place on assuring best quality healthcare, a service that touches the lives of every single EU citizen, as well as newcomers," said Pascale Blaes, Director of the ESMO Political Office in Brussels.

The Round Table session on cancer, on Thursday afternoon, 12 July, will be chaired by Dr. Joaquim Gouveia, with prominent participation of Dr. Marija Seljak, Slovenian Public Health Director, and Mr. Alojz Peterle, member of the MAC (Members of the European Parliament Against Cancer). The meeting will open with a welcome address by Prof. Hakan Mellstedt, ESMO President. "The impact of this meeting will influence the future oncology healthcare strategy throughout the European Union," he said.

Cancer is one of the major causes of disease, morbidity and mortality worldwide. Although great scientific progress has been achieved in oncology and continues to be achieved, cancer remains a huge public health challenge and a tremendous threat.

"ESMO is convinced that it is time to send a strong political signal for a broad alliance and concerted actions for the benefit of patients in Europe and worldwide and considers this event a tangible means for the Portuguese Presidency in this direction," said Prof. Mellstedt. "The Portuguese representatives, ESMO, the experts and the key forces gathering in Lisbon will call upon the European institutions to put cancer on the political agenda as a priority and will request the national governments to develop policies, including a comprehensive overall strategy, for the prevention and control of cancer."

The common objective of the meeting will be to create capacity building for developing and implementing effective policies and programs. "Only by sharing expertise and exchanging best practices in Europe, and by advocating together to get support and the appropriate political commitment, we will be able to achieve the expected relevant outcome: survival, better quality of life, and patient satisfaction," Prof. Mellstedt said.

Appropriate tools will need to be identified for the proposed policies to be effectively implemented. As a main actor in the field, with a wide expertise, ESMO, together with the Portuguese Presidency, will stress the following instruments: "It will certainly be complicated but is highly challenging," acknowledged Prof. Mellstedt.

"ESMO is proud to be associated with the Portuguese Presidency Workshop on Cancer and we are sure that it will contribute to the development of a framework for health benefits in Europe," Prof. Mellstedt continued. "The interactive format of the meeting, and its connections with other specific and global issues under discussion, will guarantee a high value contribution to the global debate on cancer and health in Europe."

ESMO will continue to support the Portuguese efforts to make this initiative a turning point in the fight against cancer in Europe and the first step towards the hoped for recognition by the national and European authorities of the recommendations agreed upon by the experts gathered together for this meeting.
-end-
Financial support for the meeting has been provided by the ESMO Foundation.

European Society for Medical Oncology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.